Functioning as a physical barrier to immune cell infiltration into the tumor (7), a collagen-dense ECM has been shown to suppress antitumor immunity and to associate with PD-1/PD-L1–resistant tumors (8, 9). The gene discussed is PDCD1; the disease is neoplasm.